Bi Asset Management Fondsmaeglerselskab A Astrazeneca PLC Transaction History
Bi Asset Management Fondsmaeglerselskab A
- $8.88 Billion
- Q1 2025
A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Astrazeneca PLC stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 594,686 shares of AZN stock, worth $43.8 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
594,686
Previous 897,750
33.76%
Holding current value
$43.8 Million
Previous $58.8 Million
25.69%
% of portfolio
0.49%
Previous 0.62%
Shares
17 transactions
Others Institutions Holding AZN
# of Institutions
1,419Shares Held
505MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.2 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.99 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.62 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.34 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.3 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...